{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:56:52Z","timestamp":1792699012172,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["561\/2023"],"award-info":[{"award-number":["561\/2023"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["IIT-0138"],"award-info":[{"award-number":["IIT-0138"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["585\/2022"],"award-info":[{"award-number":["585\/2022"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["2022\/14190-5"],"award-info":[{"award-number":["2022\/14190-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["371\/2021"],"award-info":[{"award-number":["371\/2021"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005668","name":"FAPDF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016259","name":"Viatris Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.vhri.2025.101084","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T21:12:22Z","timestamp":1739394742000},"page":"101084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cost-Effectiveness of Mineralocorticoid Receptor Antagonists in Ischemic and Nonischemic Heart Failure With Reduced Ejection Fraction: Perspective From a Universal Healthcare System"],"prefix":"10.1016","volume":"47","author":[{"given":"Cristiane","family":"Koeche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Claudia Cavalcante","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle Pinto da Silva","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana J.B.A.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmim Botelho","family":"Neiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Magno Oliveira","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Duran","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Eduardo","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei C.","family":"Sposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz S\u00e9rgio F.","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vhri.2025.101084_bib1","first-page":"149","article-title":"Impactos da insufici\u00eancia card\u00edaca no sistema de sa\u00fade e previdenci\u00e1rio brasileiro: qual \u00e9 o custo da doen\u00e7a?","volume":"14","author":"Souza","year":"2022","journal-title":"J\u00a0Bras Econ Sa\u00fade"},{"issue":"10106","key":"10.1016\/j.vhri.2025.101084_bib2","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(17)31071-1","article-title":"Heart failure","volume":"390","author":"Metra","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vhri.2025.101084_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.vhri.2025.101084_bib4","first-page":"436","article-title":"Diretriz Chronic and Acute Heart Failure","volume":"111","author":"Rohde","year":"2018","journal-title":"Arq Bras Cardiol"},{"issue":"5","key":"10.1016\/j.vhri.2025.101084_bib5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cardfail.2023.08.014","article-title":"In-hospital management and long-term clinical outcomes and adherence in patients with acute decompensated heart failure: primary results of the first\u00a0Brazilian registry of heart failure (BREATHE)","volume":"30","author":"De Albuquerque","year":"2024","journal-title":"J\u00a0Card Fail"},{"issue":"1","key":"10.1016\/j.vhri.2025.101084_bib9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.30968\/rbfhss.2022.131.0769","article-title":"Medicines regulation, pricing and reimbursement in Brazil","volume":"13","author":"Ivama-Brummell","year":"2022","journal-title":"Rev Bras Farm Hospitalar Serv Sa\u00fade"},{"issue":"4","key":"10.1016\/j.vhri.2025.101084_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jval.2019.01.006","article-title":"Bayesian networks for risk prediction using real-world data: a tool for precision medicine","volume":"22","author":"Arora","year":"2019","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.vhri.2025.101084_bib12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jval.2012.06.014","article-title":"State-transition modeling: A report of the ISPOR-SMDM modeling good research practices task Force-3","volume":"15","author":"Siebert","year":"2012","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.vhri.2025.101084_bib13","first-page":"222","article-title":"A\u00a010-year trend analysis of heart failure in the less developed Brazil","volume":"114","author":"Fernandes","year":"2020","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"10.1016\/j.vhri.2025.101084_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/eurjhf\/hfn015","article-title":"Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN\u2212CHF study): final results","volume":"11","author":"Boccanelli","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"24","key":"10.1016\/j.vhri.2025.101084_bib16","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.vhri.2025.101084_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10741-019-09832-y","article-title":"Relative Efficacy of spironolactone, eplerenone, and cAnRenone in patients with Chronic Heart failure (RESEARCH): a systematic review and network meta-analysis of randomized controlled trials","volume":"25","author":"Frankenstein","year":"2020","journal-title":"Heart Fail Rev"},{"issue":"2","key":"10.1016\/j.vhri.2025.101084_bib19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jval.2013.02.010","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"16","author":"Husereau","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2025.101084_bib20","series-title":"Decision Modelling for Health Economic Evaluation Handbooks in Health Economic Evaluation","author":"Briggs","year":"2006"},{"issue":"22","key":"10.1016\/j.vhri.2025.101084_bib22","article-title":"Causes of death in people with cardiovascular disease: a UK Biobank cohort study","volume":"10","author":"Drozd","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.vhri.2025.101084_bib23","doi-asserted-by":"crossref","DOI":"10.26633\/RPSP.2022.112","article-title":"A\u00a0declara\u00e7\u00e3o PRISMA 2020: diretriz atualizada para relatar revis\u00f5es sistem\u00e1ticas","volume":"46","author":"Page","year":"2022","journal-title":"Rev Panam Salud Publ"},{"issue":"27","key":"10.1016\/j.vhri.2025.101084_bib24","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/eurheartj\/ehw132","article-title":"A\u00a0randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and\/or chronic kidney disease","volume":"37","author":"Filippatos","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.vhri.2025.101084_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2023.100294","article-title":"Value-based health care in heart failure: quality of life and cost analysis","volume":"78","author":"Ghisleni","year":"2023","journal-title":"Clinics"},{"issue":"3","key":"10.1016\/j.vhri.2025.101084_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijcard.2011.06.046","article-title":"Cost-effectiveness of cardiac resynchronization therapy in patients with heart failure: the perspective of a middle-income country\u2019s public health system","volume":"163","author":"Bertoldi","year":"2013","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.vhri.2025.101084_bib29","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1524-4733.2008.00352.x","article-title":"Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available)","volume":"11","author":"Ara","year":"2008","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.vhri.2025.101084_bib30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00392-018-1378-0","article-title":"Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials","volume":"108","author":"Rossello","year":"2019","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"10.1016\/j.vhri.2025.101084_bib31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12872-016-0425-x","article-title":"Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis","volume":"16","author":"Berbenetz","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.vhri.2025.101084_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1236008","article-title":"Mineralocorticoid receptor antagonists for chronic heart failure: a meta-analysis focusing on the number needed to treat","volume":"10","author":"Geng","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.vhri.2025.101084_bib33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jval.2012.01.004","article-title":"Cost-effectiveness of aldosterone antagonists for the treatment of post\u2013myocardial infarction heart failure","volume":"15","author":"McKenna","year":"2012","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.vhri.2025.101084_bib34","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.CIR.90.4.1765","article-title":"A\u00a0randomized trial of beta-blockade in heart failure. The cardiac insufficiency bisoprolol study (CIBIS). CIBIS Investigators and committees","volume":"90","year":"1994","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.vhri.2025.101084_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0735-1097(97)00104-6","article-title":"Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials","volume":"30","author":"Heidenreich","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.vhri.2025.101084_bib36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jacc.2021.04.079","article-title":"Finerenone reduces new-onset atrial fibrillation in patients with chronic kidney disease and type 2 diabetes","volume":"78","author":"Filippatos","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:05:22Z","timestamp":1745985922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109925000093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":27,"alternative-id":["S2212109925000093"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101084","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Mineralocorticoid Receptor Antagonists in Ischemic and Nonischemic Heart Failure With Reduced Ejection Fraction: Perspective From a Universal Healthcare System","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101084"}}